NIH program provides a real-time risk assessment of variants

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

Related Keywords

New York , United States , Adolfo Garcia Sastre , Adolfo Garc , Michael Schotsaert , Viviana Simon , Danielle Ellis , Randy Albrecht , Evan Bakel , Florian Krammer , Us Department Of Health , National Institutes Of Health , National Institute Of Allergy , Interagency Group , Pathogens Institute At Icahn Mount Sinai , Pathogens Institute , Icahn School Of Medicine At Mount Sinai , Global Health , Genomic Sciences , Human Service , Mount Sinai Health System , Mount Sinai Pathogen Surveillance Program , Medicine Genetics , Molecular Cell Based Medicine , Icahn School , Mount Sinai , National Institutes , Viral Evolution , National Institute , Infectious Diseases , Mount Sinai Professor , Icahn Mount Sinai , Early Detection , New York City , Emerging Pathogens , Tisch Cancer Institutes , Icahn Mount , Mount Sinai Health , Emerging Pathogens Institute , Sars , Ars Cov 2 , Allergy , Bioinformatics , Fell , Children , Covid 19 , Efficacy , Revolution , Astroenterology , Enetics , Enomic , Heart , Hospital , Immunity , Mmunology , N Vitro , N Vivo , Medicine , Icrobiology , Micron , Pathology , Protein , Public Health , Eagents , Research , Spike Protein , Structural Biology , Students , Surgery , Vaccine , Virology , Virus ,